Share The chance of receiving protective antibodies after covid-19 vaccination is increased by delaying the treatment with b-cell depleters (Ocrevus and kesimpta),

Export
Embed
Code
Sort
Custom (curator specified)
Filter
Theme
Automatic (light or dark depending on user preferences)
Hide elements
Preview